Annual Meeting of the American Society for Head and Neck Surgery - American Society for Head and Neck Surgery Scholarship Award Competition (First Place in Clinical Research). Meeting. Palm Desert, Calif USA ; Palm Desert, Calif USA, 1995/04/30.
To evaluate the incidence, distribution, and course of squamous cell carcinoma (SCC) of the upper aerodigestive tract in patients infected with the human immunodeficiency virus (HIV) and compare it to SCC in non-HIV-infected patients.
Case-control study of all patients with SCC during 9.5-year period from January 1985 through June 1994.
Two academic tertiary care centers in a metropolitan location.
Five hundred thirty-nine patients (18 to 95 years old) with SCC of the upper aerodigestive tract.
Infection with HIV was present in 4.5% of the patients with SCC of the upper aerodigestive tract.
Patients infected with HIV were significantly younger than noninfected patients (P¾<. 001), accounting for 21.3% of those patients younger than 45 years (P<. 001).
No significant difference in tumor location was present between HIV-infected and noninfected patients ; however, HIV-infected patients had larger tumors (P=004) and a more advanced tumor stage (TNM classification) at presentation (P=05).
Tumor-related survival was significantly poorer in patients with HIV infection (P=01), with 57% at 1 year and 32% at 2 years, compared with 74% and 59%, for non-HIV-infected patients.
The detrimental effect of HIV infection on survival remained significant after adjusting for the confounding effects of age, tumor stage, and location of the tumor. (...)
Mots-clés Pascal : SIDA, Virose, Infection, Homme, Association, Evolutivité, Pronostic, Carcinome épidermoïde, Voie aérodigestive supérieure, Incidence, Epidémiologie, Survie, Immunopathologie, Immunodéficit, Tumeur maligne, ORL pathologie, Stomatologie
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Human, Association, Evolutivity, Prognosis, Squamous cell carcinoma, Upper aerodigestive tract, Incidence, Epidemiology, Survival, Immunopathology, Immune deficiency, Malignant tumor, ENT disease, Stomatology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0306071
Code Inist : 002B06D01. Création : 10/04/1997.